Oxford space lab experiment heads to International Space Station
Botnar Main Research
5 November 2024
The first human tissue samples from Oxford's Space Innovation Lab (SIL) have been launched and are on their way to the International Space Station, where they will be used to study the effects of space microgravity on the human ageing process.
Cellular roadmap reveals new paths to treating inflammatory bowel disease
Inflammation biology Main Research
22 October 2024
In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.
Uncovering the cellular secrets of healthy tendons
Botnar Main Research
24 June 2024
Research has unveiled the intricate cellular landscape of healthy human hamstring tendons, shedding new light on this vital yet often overlooked component of our musculoskeletal system.
Connects-UK launches to foster scientific collaborations between EU and UK researchers in a post-Brexit era
Kennedy Main Research
10 April 2024
Connects-UK, a new pan-European network dedicated to advancing scientific collaborations between researchers in the European Union (EU) and the United Kingdom (UK), was officially launched at an event in London yesterday. The network, led by a diaspora of EU researchers working in the UK, seeks to bridge the gap created by Brexit and ensure that collaboration, innovative research, funding, and knowledge exchange continue to thrive in the post-Brexit era.
New study reveals how T cells gain and maintain tolerance to gut bacteria
Inflammation biology Kennedy Main Research
4 April 2024
The immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease.
New framework guides the use of AI for clinical diagnosis
Botnar Main Research
25 March 2024
NDORMS researchers have conducted a review of the literature on the use of AI in clinical decision-making. Published in the Lancet the study identifies why AI has not yet been taken up more widely, and provides a framework to better inform future adoption and integration of the technology.
Removing bias from healthcare AI tools
Botnar Main Research Statistics and epidemiology
22 February 2024
Rapid advances in Artificial Intelligence (AI) have opened the way for the creation of a huge range of new healthcare tools, but to ensure that these tools do not exacerbate preexisting health inequities, researchers urge the use of more representative data in their development.
Frozen shoulder holds the key to understanding fibrosis resolution
Main Research Shoulder
19 February 2024
NDORMS researchers have identified how cells work to resolve frozen shoulder, opening up potential new targets for treatment and reducing the need for surgery.
New research improves accuracy of molecular quantification in high throughput sequencing
Botnar Main Research
5 February 2024
A team at NDORMS has developed a new approach to significantly improve the accuracy of RNA sequencing. They pinpoint the primary source of inaccurate quantification in both short and long-read RNA sequencing, and have introduced the concept of “majority vote” error correction leading to a substantial improvement in RNA molecular counting.